Catalyst Clinical Research

Catalyst Clinical Research provides clinical trial and drug development services to the global biotechnology and biopharmaceutical industries, delivered through two specialised divisions. Catalyst Oncology is a full-service contract research organisation focused on oncology, running trials across all phases and indications. Catalyst Flex operates as a multi-therapeutic functional service provider and CRO, offering configurable support models to sponsors. The company positions its services as customisable rather than fixed, having been founded to offer tailored and responsive solutions in place of one-size-fits-all approaches.

The firm is headquartered in Wilmington, North Carolina, and operates from 10 global locations, having grown from a single office. Its trajectory has been recognised by the Inc. 5000 list of fastest-growing private companies in the United States for five consecutive years.

Areas of work span clinical trial management, drug development, oncology clinical research, functional service provision and wider multi-therapeutic clinical research. Its client industries include biotechnology, biopharmaceuticals and oncology.

The company states a people-first approach built on five core values: listening, flexibility, collaboration, commitment and learning. Its stated purpose is to advance clinical research for innovative biopharmaceutical and biotechnology companies.